Drug Study Generic Name (Brand Name) Indication Dosage, Route, Frequency Mechanism of Action Adverse Reaction Contraindication Nursing Responsibility
Drug Study Generic Name (Brand Name) Indication Dosage, Route, Frequency Mechanism of Action Adverse Reaction Contraindication Nursing Responsibility
Drug Study Generic Name (Brand Name) Indication Dosage, Route, Frequency Mechanism of Action Adverse Reaction Contraindication Nursing Responsibility
Generic Name
(Brand Name)
Indication Dosage, Route,
Frequency
Mechanism of
Action
Adverse Reaction Contraindication Nursing
Responsibility
Methylergonovine
maleate
Methergine
Methylergobasine
Methylergobrevin
Methylergonovine)
Prevention and
treatment of
postpartum and
postabortion
hemorrhage
caused by uterine
atony or
subinvolution
2 Ampules
immediately after
the delivery of
the Placenta
Methergine
Stimulates
uterine smooth
muscles
producing
sustained
contractions
thereby shortens
the third stage of
labor
Cardiovascular:
hypertension,
temporary chest
pain, palpitation
CNS:Hallucinations,
dizziness, seizure,
headache
Gastrointestinal:
Nausea, vomiting,
diarrhea, foul taste
Local:
Thrombophlebitis
Otic: Tinnitus
Renal: Hematuria
Respiratory:
Dyspnea, nasal
congestion
> contraindicated
in patients
hypersensitive to
methylergonovine
or any component
of the
formulation.
>ergot alkaloids
are
contraindicated
with potent
inhibitors of
CYP3A4 (includes
protease
inhibitors, azole
antifungals, and
some macrolide
antibiotics);
>hypertension;
toxemia of
pregnancy (PIH)
>Be alert for
adverse reactions
and drug
interactions.
>This drug should
be used extremely
carefully because
of it's potent
vasoconstrictor
action. I.V. use
may induce
sudden
hypertension and
cerebrovascular
accidents. As a
last resort, give
I.V. slowly over
several minutes
and monitor
blood pressure
closely.
>Monitor Uterine
Contractions
Generic Name
(Brand Name)
Indication Dosage, Route,
Frequency
Mechanism of
Action
Adverse Reaction Contraindication Nursing
Responsibility
Oxytocin
(Syntocinon)
Induction of labor
at term; control of
postpartum
bleeding;
adjunctive therapy
in management of
abortion
10 units/ml in
1ml ampule, vial
or syringe in
compatible IV
solution.
to induce or milk
ejection and
stimulate
contraction
Hypersensitive
to drug when
vaginal delivery
is advised
- cephalopelvic
disproportion is
present
-when delivery
requires
conversion as in
transverse lie
CV:
Hypertension,
increased heart
rate, systemic
venous return,
cardiac output
GI: Nausea,
vomiting
RESPIRATORY:
Anoxia, asphyxia
OTHERS:
Low APGAR
score at 5 mins.
Continuously
monitor
contractions,
fetal and
maternal
heart rate, and
maternal
blood
pressure and
ECG.
Discontinue
infusion if
uterine
hyperactivity
occurs.
Monitor
patient
extremely
closely during
first and
second stages
of labor
because of risk
of cervical
laceration,
uterine
rupture and
maternal and
fetal death.